| Product Code: ETC11813646 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
India`s carfilzomib import market in 2024 continued to see high concentration with a high Herfindahl-Hirschman Index (HHI). The top exporting countries to India were the USA, Metropolitan France, South Korea, Brazil, and India itself. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 36.8%, indicating significant market expansion. Additionally, the growth rate from 2023 to 2024 stood at 1.06%, showcasing steady progress in the import of carfilzomib into India.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Carfilzomib Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Carfilzomib Market Revenues & Volume, 2021 & 2031F |
3.3 India Carfilzomib Market - Industry Life Cycle |
3.4 India Carfilzomib Market - Porter's Five Forces |
3.5 India Carfilzomib Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Carfilzomib Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Carfilzomib Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Carfilzomib Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Carfilzomib Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple myeloma in India |
4.2.2 Growing awareness about advanced cancer treatments |
4.2.3 Rising healthcare expenditure and improving access to oncology drugs |
4.3 Market Restraints |
4.3.1 High cost of carfilzomib treatment |
4.3.2 Limited reimbursement policies for cancer drugs in India |
4.3.3 Regulatory hurdles and approval process for new drugs |
5 India Carfilzomib Market Trends |
6 India Carfilzomib Market, By Types |
6.1 India Carfilzomib Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Carfilzomib Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Carfilzomib Market Revenues & Volume, By Carfilzomib Injection, 2021 - 2031F |
6.1.4 India Carfilzomib Market Revenues & Volume, By Generic Carfilzomib, 2021 - 2031F |
6.1.5 India Carfilzomib Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.1.6 India Carfilzomib Market Revenues & Volume, By Research Use Drugs, 2021 - 2031F |
6.2 India Carfilzomib Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Carfilzomib Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.2.3 India Carfilzomib Market Revenues & Volume, By Small Molecule Drugs, 2021 - 2031F |
6.2.4 India Carfilzomib Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.5 India Carfilzomib Market Revenues & Volume, By Bioinformatics Analysis, 2021 - 2031F |
6.3 India Carfilzomib Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Carfilzomib Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.3.3 India Carfilzomib Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.3.4 India Carfilzomib Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.5 India Carfilzomib Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 India Carfilzomib Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Carfilzomib Market Revenues & Volume, By Multiple Myeloma Treatment, 2021 - 2031F |
6.4.3 India Carfilzomib Market Revenues & Volume, By Cost-effective Cancer Treatment, 2021 - 2031F |
6.4.4 India Carfilzomib Market Revenues & Volume, By Enhanced Treatment Effectiveness, 2021 - 2031F |
6.4.5 India Carfilzomib Market Revenues & Volume, By Cancer Drug Development, 2021 - 2031F |
7 India Carfilzomib Market Import-Export Trade Statistics |
7.1 India Carfilzomib Market Export to Major Countries |
7.2 India Carfilzomib Market Imports from Major Countries |
8 India Carfilzomib Market Key Performance Indicators |
8.1 Patient adoption rate of carfilzomib therapy |
8.2 Number of clinical trials and research studies on carfilzomib in India |
8.3 Rate of oncologists prescribing carfilzomib for multiple myeloma treatment |
9 India Carfilzomib Market - Opportunity Assessment |
9.1 India Carfilzomib Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Carfilzomib Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Carfilzomib Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Carfilzomib Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Carfilzomib Market - Competitive Landscape |
10.1 India Carfilzomib Market Revenue Share, By Companies, 2024 |
10.2 India Carfilzomib Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here